1. Proteomics and metabolic phenotyping define principal roles for the aryl hydrocarbon receptor in mouse liver
- Author
-
Banrida Wahlang, Monika Thapa, Michael L. Merchant, Jian Jin, Sudhir Srivastava, Josiah E. Hardesty, Russell A. Prough, Shesh N. Rai, Matthew C. Cave, and Kimberly Z. Head
- Subjects
WT, wild type ,TAT, tyrosine aminotransferase ,PCB126 ,AHR ,IGF1, insulin-like growth factor 1 ,PCB, polychlorinated biphenyl ,Blood lipids ,FGF21, fibroblast growth factor 21 ,miR, microRNA ,Pheromones ,AHR, aryl hydrocarbon receptor ,AUC, area under the curve ,Liver disease ,HFD, high fat diet ,AST, aspartate transaminase ,LDL, low-density lipoprotein ,VLDL, very low-density lipoprotein ,Environmental liver disease ,General Pharmacology, Toxicology and Pharmaceutics ,Receptor ,MUP, major urinary protein ,ANOVA, analysis of variance ,NFKBIA, nuclear factor kappa-inhibitor alpha ,PNPLA3, patatin-like phospholipase domain-containing protein 3 ,biology ,ZFP125, zinc finger protein 125 ,PXR, pregnane-xenobiotic receptor ,MCP-1, monocyte chemoattractant protein-1 ,respiratory system ,EPF, enrichment by protein function ,IL-6, interleukin 6 ,nHDLc, non-HDL cholesterol ,IPF, interaction by protein function ,PAI-1, plasminogen activator inhibitor-1 ,PLIN2, perilipin-2 ,Proteome ,CYP, cytochrome P450 ,Original Article ,CAR, constitutive androstane receptor ,SGK1, serum/glucocorticoid regulated kinase ,NAFLD, non-alcoholic fatty liver disease ,medicine.medical_specialty ,FDR, false discovery rate ,ALT, alanine transaminase ,Endocrine disruption ,HDL, high-density lipoprotein ,H&E, hematoxylin-eosin ,RM1-950 ,CD36, cluster of differentiation 36 ,Perilipin-2 ,Internal medicine ,medicine ,Nonalcoholic fatty liver disease ,Pheromone binding ,GO, gene ontology ,TASH, toxicant-associated steatohepatitis ,PPARα, peroxisome proliferator-activated receptor alpha ,TAFLD, toxicant-associated fatty liver disease ,TMT, tandem mass tag ,medicine.disease ,Aryl hydrocarbon receptor ,Insulin receptor ,Endocrinology ,biology.protein ,GCR, glucocorticoid receptor ,Therapeutics. Pharmacology ,Steatosis - Abstract
Dioxin-like molecules have been associated with endocrine disruption and liver disease. To better understand aryl hydrocarbon receptor (AHR) biology, metabolic phenotyping and liver proteomics were performed in mice following ligand-activation or whole-body genetic ablation of this receptor. Male wild type (WT) and Ahr–/– mice (Taconic) were fed a control diet and exposed to 3,3′,4,4′,5-pentachlorobiphenyl (PCB126) (61 nmol/kg by gavage) or vehicle for two weeks. PCB126 increased expression of canonical AHR targets (Cyp1a1 and Cyp1a2) in WT but not Ahr–/–. Knockouts had increased adiposity with decreased glucose tolerance; smaller livers with increased steatosis and perilipin-2; and paradoxically decreased blood lipids. PCB126 was associated with increased hepatic triglycerides in Ahr–/–. The liver proteome was impacted more so by Ahr–/– genotype than ligand-activation, but top gene ontology (GO) processes were similar. The PCB126-associated liver proteome was Ahr-dependent. Ahr principally regulated liver metabolism (e.g., lipids, xenobiotics, organic acids) and bioenergetics, but it also impacted liver endocrine response (e.g., the insulin receptor) and function, including the production of steroids, hepatokines, and pheromone binding proteins. These effects could have been indirectly mediated by interacting transcription factors or microRNAs. The biologic roles of the AHR and its ligands warrant more research in liver metabolic health and disease., Graphical abstract The aryl hydrocarbon receptor regulated liver metabolism and endocrine function impacting systemic energy homeostasis and body composition. This regulation appeared to involve both direct and indirect mechanisms.Image 1
- Published
- 2021